Optimum News

Optimum Strategic Communications Appoints Leading Healthcare Investor Anne Marieke Ezendam

Renowned fund manager and buyside analyst joins investor relations and strategic communications specialists 7 November 2018, London, UK: Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, announces the … Continue reading “Optimum Strategic Communications Appoints Leading Healthcare Investor Anne Marieke Ezendam”

Read more

By Optimum

Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting

Amsterdam, The Netherlands, November 7, 2018 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces two data presentations at … Continue reading “Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting”

By Optimum

Novo Seeds incubatee Embark Biotech enters collaboration with Novo Nordisk to discover novel therapeutics for obesity and metabolic disease

Embark was first incubated by Novo Seeds and funded through the pre-seed grant programme of the Novo Nordisk Foundation in 2016 Embark co-founder and CEO, Casper Tind Hansen, serves as … Continue reading “Novo Seeds incubatee Embark Biotech enters collaboration with Novo Nordisk to discover novel therapeutics for obesity and metabolic disease”

By Optimum

Futura Medical Announces First Patient Enrolled in European Phase 3 study of MED2002 for the Treatment of Erectile Dysfunction

Futura Medical plc (AIM: FUM) (the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology currently focused on sexual health … Continue reading “Futura Medical Announces First Patient Enrolled in European Phase 3 study of MED2002 for the Treatment of Erectile Dysfunction”

By Optimum

Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare

Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare 10th Annual Healthcare Investor conference Expert panellists include public, private investors and leading European companies 12 October … Continue reading “Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare”

By Optimum

Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and Nivolumab (Opdivo®) with Standard of Care

CALGARY, Alberta and SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (TSX: ONC) (NASDAQ: ONCY), currently developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors … Continue reading “Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and Nivolumab (Opdivo®) with Standard of Care”

By Optimum

ARIX Bioscience Plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to retire from Board

LONDON, 12 September 2018: Arix Bioscience plc (“Arix”) (LSE: ARIX), a global healthcare and life science company supporting medical innovation, today announced that industry veteran Arthur Pappas has been appointed … Continue reading “ARIX Bioscience Plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to retire from Board”

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH